19-12891895-G-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000159.4(GCDH):c.192G>T(p.Glu64Asp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000159.4 missense
Scores
Clinical Significance
Conservation
Publications
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.192G>T | p.Glu64Asp | missense_variant | Exon 4 of 12 | ENST00000222214.10 | NP_000150.1 | |
| GCDH | NM_013976.5 | c.192G>T | p.Glu64Asp | missense_variant | Exon 4 of 12 | NP_039663.1 | ||
| GCDH | NR_102316.1 | n.300G>T | non_coding_transcript_exon_variant | Exon 4 of 12 | ||||
| GCDH | NR_102317.1 | n.608G>T | non_coding_transcript_exon_variant | Exon 3 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GCDH | ENST00000222214.10 | c.192G>T | p.Glu64Asp | missense_variant | Exon 4 of 12 | 1 | NM_000159.4 | ENSP00000222214.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1 Pathogenic:4
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 64 of the GCDH protein (p.Glu64Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with glutaric acidemia type I (PMID: 24973495). ClinVar contains an entry for this variant (Variation ID: 550794). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GCDH protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
In silico analysis of the p.Glu64Asp variant predicted it as deleterious. Seven different bioinformatic tools (PolyPhen-2, SIFT, PANTHER, Condel, Eris, Mupro and PhD-SNP) were used for this prediction. The p.Glu64Asp variant has been also reported in a family of Arab-Muslim first-degree consanguineous parents with their second found to be affected (Pode-Shakked et., 2014).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at